|
The enigma of the cancer process Among the many problems of oncology, what more interests the scientists is the way through which the cancer cells form. For the classic oncology the cancer cell originates from cells considered healthy. When a tumour develops, is general consensus that one or more immobile and healthy cells starts "moving about". By quickly splitting they trigger a vigorous proliferation that forms the malignant tumour. Besides we know that the cancer cells, contrarily to what happens for the healthy cells, can move and penetrate the surrounding tissues. How is it possible that a healthy and immobile cell, that lives and works with other healthy cells, detaches from them, acquires motility and becomes "wild", is able to destroy an organism? Besides, knowing that from the vital point of view, the cancer cell is a very weak structure and can be easily destroyed, how that can happen? As a matter of fact, the traditional oncology really does not know what happens between the healthy state and the state of the disease. It is a mistake to believe that the cancer cell develops directly from the healthy cells. Indeed, much time before, in the hit tissue a series of pathological processes is taking place that announces and precedes the cancer cell. The malignant tumour is not the most important thing of cancer. It represents only the most visible manifestation of the disease. If the fight against the cancer has not made progresses yet, this is mostly due to the fact that the local tumour is considered the true disease ignoring that the cancer could be instead a disease of the whole organism. The fully developed cancer cell is indeed an end product of a long series of processes that happen in the hit tissues. Typical phases, absent in a healthy tissue, that from the decomposition of the tissues lead us to these formations, can be found. The healthy and living cells are characterized by bluish protoplasm. In cancer tissues the same cells show inside dark blue bionous vesicles or very small black corpuscles. The potentially cancer cell or the cancer cell itself differs from the healthy cell since, when cooked, it fragments in T particles rather than large bions PA and this is not depending from the examined tissues and from the type of tumour. The tumour (with observations in-vivo) is characterized by a vesicular structure of the cells, that compose the surrounding tissues, and by various phases of development of the cancer cell or by vesicles that originate from the decomposition itself. The first step in the development of a malignant tumour is always and everywhere the bionous vesicular breaking up of the tissue. The basic shape of a cancer cell is typical and unique for all the types of cancer. It is club-shaped with a tail, and the breadth instead can be very variable. They can be large or small. Those small, for reasons still unknown, are much more dangerous and lead to death much faster. It is important to notice that this shape does not exist in other healthy somatic cell (only in the gastric mucus we find cylindrical cells that, to a superficial examination, can be similar to our cancer formations) The cancer cells simply stems from a vesicular decomposition of the original cells and from reforming (of the vesicles) again inside the organism or the same cell. At the end, the cells of the tissues of the involved organism transform in a mass of unicellular organisms of different and various shapes. If this process could go ahead without death can occur, the hit organism would transform itself in a muddy mass of protozoa.
In the cancer the normal process of generalized necrosis, that naturally begins with the old age, is anticipated and accelerated. It is a premature but regular process. Its pathological essence consists only in the precocity and the acceleration through which this process develops. The disturbance interests in particular way the blood system and then all the organism. The decomposing cancer tissue is always putrescent and the end product is always represented from an extraordinary quantity of corpuscles T (test of the autoclave). They constitute a serious danger for the organism: the greater the number of decomposing cancer cells the greater the subsequent T poisoning. For our therapy, the real difficulty is not to be found in the tumour destruction but in the expulsion from the body of the products consequence of the putrefaction and the decomposition. It is possible to check the state of putrefaction of the organism by performing a test on the blood. Even from the simple lesion of a tissue we can have products that can degenerate in corpuscles T and can stimulate the cancer proliferation. A classic example is the formation of tumours from the damaging caused by a dental prosthesis. However, what it counts is not, as one can think, the local damaging of the tissue, but the quantity of the starting energetic charge of the organism. It would be the right time for the classic medicine to develop more and more the assumption that the specific agent and the pathological cause become active only when the organism allows it.
The very first step in the development of a malignant tumour is not the cancer cell and neither its disintegration in bions PA but it is the mass of T bodies that appear in the tissues.
They can be found again in healthy organisms and this can seem nonsense. It should be explained that the healthy organism can be distinguished from the cancer one not for the absence of corpuscles T but for the energetic charge, hence for the capacity to hold them and for the low tendency of its tissues to disintegrate. The tendency towards the cancer is therefore an universal fact. Do not exists one true and just cancerous element. However, until to the time the organism is strong enough every T bacillus is destroyed or disarmed. The predisposition to the cancer can be therefore determined by observing the biological resistance of the blood and the tissues to putrefaction that in turn is determined from the energetic charge and from the potency of the organism (it is on this assumption that the tests of the blood for the early diagnosis of cancer are based).
|